Literature DB >> 9884673

Child and adolescent psychopharmacology. Important developmental issues.

M C Tosyali1, L L Greenhill.   

Abstract

This article begins with an overview of developmental variations in pharmacokinetics and pharmacodynamics and then discusses issues related to decision making before beginning treatment with medication, including diagnosis, impairment, and consent. Subsequently, specific disorders, such as attention deficit hyperactivity disorder, mood disorders, and obsessive-compulsive disorder, are briefly discussed, with focus on issues relevant to a developmental approach to pediatric psychopharmacology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9884673     DOI: 10.1016/s0031-3955(05)70060-2

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  4 in total

1.  The Subjective Experience of Youth Psychotropic Treatment.

Authors:  Jerry Floersch
Journal:  Soc Work Ment Health       Date:  2004-03-01

Review 2.  The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD).

Authors:  B H Smith; D A Waschbusch; M T Willoughby; S Evans
Journal:  Clin Child Fam Psychol Rev       Date:  2000-12

Review 3.  Depression in children and adolescents: does gender make a difference?

Authors:  Elizabeth B Weller; Angelica Kloos; Joon Kang; Ronald A Weller
Journal:  Curr Psychiatry Rep       Date:  2006-04       Impact factor: 5.285

4.  Assessing psychiatric patients for violence.

Authors:  Tanya R Anderson; Carl C Bell; Traci E Powell; Johnny L Williamson; Morris A Blount
Journal:  Community Ment Health J       Date:  2004-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.